[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 18, Issue 4 (winter 2019) ::
J Ardabil Univ Med Sci 2019, 18(4): 479-487 Back to browse issues page
Alterations in the Expression Level of mir-1246 and mir-224 in Breast Cancer Cell Lines After Treatment with Taxol Chemotherapeutic Agent
Navideh Haghnavaz , Faezeh Asghari , Zeynab Sattari , Monire Babaei , Tohied Kazemi
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract:   (2861 Views)
Background & objectives: Breast cancer is one of the most important cancers in women worldwide. Taxol as a chemotherapeutic agent, is used for treatment of breast cancer.The aim of this study was to investigate alterations in the expression of mir-1246 and mir-224 in four breast cancer cell lines after Taxol treatment with the goal of introducing them as a biochemical marker for determining response or resistance of breast cancer to the Taxol therapy.
Methods: In this in vitro study, four breast cancer cell lines including MCF-7, MDA-MB-231, SKBR-3 and BT-474 were cultured in RPMI1640 medium supplemented with 10% FBS and antibiotics. Then, MTT assay was performed to determine IC50 concentration of Taxol. Cells were treated for 24 hours and then RNA extraction and cDNA synthesis were performed. Alterations in the expression level of mir-1246 and mir-224 were quantitated using qRT- PCR.
Results: After treatment with Taxol, the expression level of mir-1246 was significantly up-regulated in two HER2-overexpressing cell lines, BT-474 (113 fold) and SKBR-3 (1.4 fold), and down-regulated in two HER2-negative cell lines, MCF-7 (45.5 fold) and MDA-MB-231 (7.7 fold). Expression of mir-224 was detected only in two cell lines including SKBR-3 and MDA-MB-231, and was down-regulated after treatment with Taxol (2.1 and 17.2 fold, respectively).
Conclusions: According to the different pattern of alteration in the expression level of mir-1246 in HER2-overexpressing breast cancer cell lines compared to HER2-negative cell lines after treatment with Taxol, this miRNA could be a useful biomarker for responsiveness to Taxol in  different types of HER2-positive and -negative breast cancers.
 
Keywords: Breast Cancer, Taxol, mir-1246, mir-224
Full-Text [PDF 197 kb]   (414 Downloads)    
Type of Study: article | Subject: هماتولوژی و انکولوژی
Received: 2018/10/22 | Accepted: 2018/12/21 | Published: 2018/12/31
Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Haghnavaz N, Asghari F, Sattari Z, Babaei M, Kazemi T. Alterations in the Expression Level of mir-1246 and mir-224 in Breast Cancer Cell Lines After Treatment with Taxol Chemotherapeutic Agent . J Ardabil Univ Med Sci. 2019; 18 (4) :479-487
URL: http://jarums.arums.ac.ir/article-1-1630-en.html


Volume 18, Issue 4 (winter 2019) Back to browse issues page
مجله دانشگاه علوم پزشکی اردبیل Journal of Ardabil University of Medical Sciences
Persian site map - English site map - Created in 0.1 seconds with 32 queries by YEKTAWEB 4122